Jump to content
The World News Media

FDA frets over the safety of Sanofi's diabetes combo - FierceBiotech


Health and Medicine

Recommended Posts

  • Administrator
images?q=tbn:ANd9GcQAgYI5K1ZBRlIIDbxAuqi
FierceBiotech

FDA frets over the safety of Sanofi's diabetes combo
FierceBiotech
The FDA has set up a debate among outside experts over Sanofi's ($SNY) combo diabetes drug LixiLan today by raising a series of red flags over potential safety issues that could arise if the combination is allowed to reach the market. In particular ...
Sanofi's executive VP for diabetes to leave companyReuters
Sanofi shakes up management team as top diabetes exec departs, consumer business expandsFiercePharma
FDA Staff Questions Usefulness of Sanofi's Diabetes Drug ComboBloomberg
Medical Daily -Bidness ETC -BioPharma Dive -Reuters UK
all 10 news articles »

Google

Link to comment
Share on other sites


  • Views 284
  • Replies 0
  • Created
  • Last Reply

Top Posters In This Topic

Popular Days

Top Posters In This Topic

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...




×
×
  • Create New...

Important Information

Terms of Service Confirmation Terms of Use Privacy Policy Guidelines We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.